Ascletis to Present at the 17th Annual Morgan Stanley Asia Pacific Summit

Hangzhou & Shaoxing, China (Nov. 26, 2018) -- Ascletis Pharma Inc. (1672.HK), a commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Dr. Jinzi J. Wu, Founder, Chairman and CEO of Ascletis will present at the 17th Annual Morgan Stanley Asia Pacific Summit in Singapore. The presentation is scheduled for 16:30 PM SGT on Wednesday, November 28, 2018.